Compare CSX Corporation (CSX) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Novo Nordisk A/S — how do they compare? CSX Corporation trades at $50.03 (market cap $92.55B), while Novo Nordisk A/S trades at $45.79 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 2.2× CSX Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| CSX | NVO | |
|---|---|---|
Market Cap | $92.55B | $207.85B |
Sector | Industrials | Health |
52-Week High | $53.21 | $63.98 |
52-Week Low | $32.05 | $35.29 |
Enterprise Value | $110.52B | $222.55B |
Dividend Yield | 1.12% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
